dc.contributor.author | Koponen, Marjaana | |
dc.date.accessioned | 2020-10-30T11:02:22Z | |
dc.date.available | 2017-09-20 | |
dc.date.issued | 2017-09-28 | |
dc.identifier.isbn | 978-952-61-2572-5 | |
dc.identifier.uri | https://erepo.uef.fi/handle/123456789/18480 | |
dc.language.iso | en | |
dc.publisher | Itä-Suomen yliopisto | fi |
dc.publisher | University of Eastern Finland | en |
dc.relation.ispartofseries | Publications of the University of Eastern Finland. Dissertations in Health Sciences | |
dc.relation.isversionof | 978-952-61-2571-8 | |
dc.subject | Alzheimer Disease | |
dc.subject | Antipsychotic Agents | |
dc.subject | Incidence | |
dc.subject | Prevalence | |
dc.subject | Drug-Related Side Effects and Adverse Reaction | |
dc.subject | Risk | |
dc.subject | Hip Fractures | |
dc.subject | Mortality | |
dc.subject | Cohort Studies | |
dc.subject | Longitudinal Studes | |
dc.subject | Follow-Up Studies | |
dc.subject | Pharmacoepidemiology | |
dc.subject | Drug Utilization | |
dc.subject | Polypharmacy | |
dc.subject | Registries | |
dc.subject | Finland | |
dc.title | Antipsychotic use and risk of hip fracture and mortality among community dwellers with Alzheimer's disease : a nationwide register-based study | |
dc.type.publication | info:eu-repo/semantics/doctoralThesis | |
dc.contributor.organization | Terveystieteiden tiedekunta | fi |
dc.contributor.organization | Faculty of Health Sciences | en |
dc.format.content | abstractOnly | |
dc.identifier.urn | http://urn.fi/URN:ISBN:978-952-61-2572-5 | |
dc.publisher.country | fi | |
dc.relation.issn | 1798-5714 | |
dc.relation.numberinseries | 429 | |
dc.rights.accesslevel | openAccess | |
dc.type.ontasot | Väitöskirja | fi |
dc.type.ontasot | Doctoral dissertation | en |
uef.publication.id | 11375 | |
dc.contributor.faculty | Terveystieteiden tiedekunta | fi |
dc.contributor.faculty | Faculty of Health Sciences | en |
dc.format.displayContent | Julkaisusta vain yhteenveto-osa | fi |
dc.format.displayContent | Abstract available only | en |
dc.subject.ysa | Alzheimerin tauti | |
dc.subject.ysa | psykoosit | |
dc.subject.ysa | psyykenlääkkeet | |
dc.subject.ysa | haitat | |
dc.subject.ysa | riskit | |
dc.subject.ysa | ilmaantuvuus | |
dc.subject.ysa | esiintyvyys | |
dc.subject.ysa | luunmurtumat | |
dc.subject.ysa | lonkka | |
dc.subject.ysa | kuolleisuus | |
dc.subject.ysa | kohorttitutkimus | |
dc.subject.ysa | pitkittäistutkimus | |
dc.subject.ysa | seurantatutkimus | |
dc.subject.ysa | epidemiologia | |
dc.subject.ysa | lääkkeet | |
dc.subject.ysa | polyfarmasia | |
dc.subject.ysa | rekisterit | |
dc.subject.ysa | Suomi | |
dc.type.coar | http://purl.org/eprint/type/Thesis | |
dc.type.displayType | Väitöskirja | fi |
dc.type.displayType | Dissertation | en |